Scientists developed an interactive artificial pancreas that uses digital twins to improve blood sugar control in type 1 diabetes patients.

Researchers at the University of Colorado, Boulder, made the discovery after exposing human cells to the sweetener in the lab ...

The portfolio continues to invest in companies we believe are strong and improving and have improvement that is sustainable.

UBS is holding firm on its Buy rating and $1,050 price target for Eli Lilly, driven by faith in the upcoming SURPASS-CVOT ...